Dhanvantri Jeevan Rekha Ltd.
| BSE: 531043 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE239F01015 |
| BSE 00:00 | 25 Jan | 7.70 |
0 (0.00%) |
OPEN
7.70 |
HIGH
7.70 |
LOW
7.70 |
| NSE 05:30 | 01 Jan | Dhanvantri Jeevan Rekha Ltd |
| OPEN | 7.70 |
| PREVIOUS CLOSE | 7.70 |
| VOLUME | 98 |
| 52-Week high | 8.56 |
| 52-Week low | 4.34 |
| P/E | |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 7.70 |
| Buy Qty | 48.00 |
| Sell Price | 7.70 |
| Sell Qty | 52.00 |
Dhanvantri Jeevan Rekha Ltd. (DHANVANTRIJEEV) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 959.45 | -38.55 | -3.86 | 13266.48 |
| Cipla | 842.10 | 5.00 | 0.60 | 12659.15 |
| Sun Pharma.Inds. | 569.80 | -16.75 | -2.86 | 12531.93 |
| Dr Reddy's Labs | 4908.85 | -173.25 | -3.41 | 11850.40 |
| Lupin | 1074.25 | -7.60 | -0.70 | 11025.66 |
| Apollo Hospitals | 2599.45 | -87.70 | -3.26 | 9794.50 |
| Glenmark Pharma. | 485.50 | -5.80 | -1.18 | 6712.63 |
| Alkem Lab | 3059.55 | -50.50 | -1.62 | 6677.08 |
| Cadila Health. | 462.20 | -4.65 | -1.00 | 6347.40 |
| Torrent Pharma. | 2646.25 | 10.35 | 0.39 | 6168.44 |
| Divi's Lab. | 3483.90 | -86.90 | -2.43 | 5310.57 |
| Ipca Labs. | 1944.30 | -36.60 | -1.85 | 4337.82 |
| Piramal Enterp. | 1421.20 | -45.60 | -3.11 | 4219.19 |
| Alembic Pharma | 952.25 | -8.25 | -0.86 | 4132.55 |
| Abbott India | 14531.35 | -4.55 | -0.03 | 4093.14 |
| Glaxosmi. Pharma | 1469.05 | -19.85 | -1.33 | 3224.68 |
| Jubilant Life | 927.20 | 38.70 | 4.36 | 3139.90 |
| Sanofi India | 7990.45 | -313.00 | -3.77 | 3070.60 |
| Laurus Labs | 366.20 | -13.15 | -3.47 | 2797.34 |
| Gland Pharma | 2184.65 | -64.70 | -2.88 | 2633.24 |
Quick Links for Dhanvantri Jeevan Rekha:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
